USNA Usana Health Sciences Inc
- Stocks
- Consumer Defensive
- NYSE: USNA
Price (delayed)
$28.85
Market cap
$527.14M
P/E Ratio
16.03
Dividend/share
N/A
EPS
$1.8
Enterprise value
$375.8M
USANA prides itself in providing consumers the highest quality nutritional products in the world. From its award-winning supplements to its innovative skincare line, USANA has proven for more than 25
Highlights
USNA's debt has plunged by 100% from the previous quarter and by 100% YoY
USNA's revenue is up by 2.8% year-on-year and by 2.6% since the previous quarter
USNA's net income is down by 38% year-on-year and by 2.2% since the previous quarter
The EPS has contracted by 37% YoY
Key stats
What are the main financial stats of USNA
Market
Valuations
Earnings
Shares outstanding
18.27M
Market cap
$527.14M
Enterprise value
$375.8M
Price to earnings (P/E)
16.03
Price to book (P/B)
1.01
Price to sales (P/S)
0.59
EV/EBIT
5.81
EV/EBITDA
3.91
EV/Sales
0.42
Revenue
$899.22M
Gross profit
$718.78M
Operating income
$56.2M
Net income
$34.12M
EBIT
$64.73M
EBITDA
$96.03M
Free cash flow
$51.05M
Per share
Balance sheet
Liquidity
EPS
$1.8
EPS diluted
$1.8
Free cash flow per share
$2.76
Book value per share
$28.52
Revenue per share
$48.57
TBVPS
$24.17
Total assets
$734.53M
Total liabilities
$148.97M
Debt
$0
Equity
$531.06M
Working capital
$140.24M
Debt to equity
0
Current ratio
2.15
Quick ratio
1.24
Net debt/EBITDA
-1.58
Margins
Efficiency
Dividend
EBITDA margin
10.7%
Gross margin
79.9%
Net margin
3.8%
Operating margin
6.2%
Return on assets
4.7%
Return on equity
6.4%
Return on invested capital
40.8%
Return on capital employed
10.6%
Return on sales
7.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
USNA stock price
How has the Usana Health Sciences stock price performed over time
Intraday
-0.48%
1 week
-0.03%
1 month
-11.8%
1 year
-26.4%
YTD
-19.62%
QTD
-5.5%
Financial performance
How have Usana Health Sciences's revenue and profit performed over time
Revenue
$899.22M
Gross profit
$718.78M
Operating income
$56.2M
Net income
$34.12M
Gross margin
79.9%
Net margin
3.8%
USNA's net margin is down by 40% YoY and by 5% from the previous quarter
USNA's net income is down by 38% year-on-year and by 2.2% since the previous quarter
Usana Health Sciences's operating margin has decreased by 35% YoY and by 4.6% QoQ
The operating income has declined by 33% year-on-year
Price vs fundamentals
How does USNA's price correlate with its fundamentals
Growth
What is Usana Health Sciences's growth rate over time
Valuation
What is Usana Health Sciences stock price valuation
P/E
16.03
P/B
1.01
P/S
0.59
EV/EBIT
5.81
EV/EBITDA
3.91
EV/Sales
0.42
The EPS has contracted by 37% YoY
The price to earnings (P/E) is 3.4% higher than the last 4 quarters average of 15.5
USNA's P/B is 64% below its 5-year quarterly average of 2.8 and 16% below its last 4 quarters average of 1.2
USNA's price to sales (P/S) is 51% less than its 5-year quarterly average of 1.2 and 16% less than its last 4 quarters average of 0.7
USNA's revenue is up by 2.8% year-on-year and by 2.6% since the previous quarter
Efficiency
How efficient is Usana Health Sciences business performance
Usana Health Sciences's ROA has decreased by 41% YoY and by 2.1% from the previous quarter
The ROE has contracted by 40% YoY and by 3% from the previous quarter
The company's return on invested capital fell by 37% YoY and by 6% QoQ
The ROS has contracted by 33% YoY and by 5% from the previous quarter
Dividends
What is USNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for USNA.
Financial health
How did Usana Health Sciences financials performed over time
Usana Health Sciences's total liabilities has decreased by 8% QoQ and by 8% YoY
The current ratio has increased by 8% YoY and by 4.9% from the previous quarter
USNA's debt is 100% less than its equity
USNA's debt has plunged by 100% from the previous quarter and by 100% YoY
The debt to equity has plunged by 100% from the previous quarter and by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.